References
- Schantz S P, Hsu T C. Head and neck cancer patients express increased clastogen-induced chromosome fragility. Head Neck Surg 1989; 11: 337–43
- Choi S Y, Kahyo H. Effect of cigarette smoking and alcohol consumption in the aetiology of cancer of the oral cavity, pharynx and larynx. Int J Epidemiol 1991; 20: 878–85
- Mashberg A, Boffetta P, Winkelman R, Garfinkel L. Tobacco smoking, alcohol drinking, and cancer of the oral cavity and oropharynx among U.S. veterans. Cancer 1993; 72: 1369–75
- Harris C C, Hollstein M. Clinical implications of the p53 tumor suppressor gene. N Engl J Med 1993; 329: 1318–27
- Brachman D G, Graves D, Vokes E, et al. Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer. Cancer Res 1992; 62: 4832–6
- Somers K D, Merrick M A, Lopez M E, et al. Frequent p53 mutations in head and neck cancer. Cancer Res 1992; 52: 5997–6000
- Watling D L, Gown A M, Coltrera M D. Overexpression of p53 in head and neck cancer. Head Neck 1992; 14: 437–44
- Pavelic Z P, Gluckman J L, Gapany M, et al. Improved immunohistochemical detection of p53 protein in paraffin-embedded tissues reveals elevated levels in most head and neck and lung carcinomas: Correlation with clinicopathological parameters. Anticancer Res 1992; 12: 1389–94
- Chang Y S, Lin Y J, Tsai C N, et al. Detection of mutations in the p53 gene in human head and neck carcinomas by single strand conformation polumorphism analysis. Cancer Lett 1992; 67: 167–74
- Yin X Y, Smith M L, Whiteside T L, et al. Abnormalities in the p53 gene in tumors and cell lines of human squamous cell carcinomas of the head and neck. Int J Cancer 1993; 54: 322–7
- Field J K, Spandidos D A, Malliri A, et al. Elevated p53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck. Br J Cancer 1991; 64: 573–7
- Pekkola-Heino K, Kulmala J, Klemi P, et al. Effects of radiation fractination on four squamous cell carcinoma cell lines with dissimilar inherent radiation sensitivity. J Cancer Res Clin Oncol 1991; 117: 597–602
- Pekkola-Heino K, Joensuu H, Klemi P, Grénman R. Relation of DNA ploidy and proliferation rate to radiation sensitivity in squamous cell carcinoma cell lines. Arch Otolaryngol Head Neck Surg 1994; 120: 750–4
- Servomaa K, Kiuru A, Grénman R., Pekkola-Heino K, Pulkkinen J O, Rytömaa T. p53 mutations associated with increased sensitivity to ionizing radiation in human head and neck cancer cell lines. Cell Prolif 1996; 29: 219–30
- Pekkola-Heino K, Servomaa K, Kiuru A, Grénman R. Increased radiosensitivity is associated with p53 mutations in cell lines derived from oral cavity carcinoma. Acta Otolaryngol (Stockh) 1996; 116: 341–4
- Hollstein M, Shomer B, Greenblatt M, et al. Somatic point mutations in the p53 gene of human tumors and cell lines: updated complication. Nucl Acids Res 1996; 24: 141–6
- Greenblatt M S, Bennett W P, Hollstein M, Harris C C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994; 54: 4855–78
- Ahomadegbe J C, Barrois M, Fogel S, et al. High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions. Oncogene 1995; 10: 1217–27
- Gaidano G, Ballerini P, Gong J Z, et al. p53 mutations in human lymphoid malignancies: Association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA 1991; 88: 5413–5417